Dr. Garg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
105 Hickory Ct
Danville, CA 94506Phone+1 847-347-6579
Education & Training
- Kaiser Permanente Northern California (Oakland)Residency, Internal Medicine, 2008 - 2011
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2008
Certifications & Licensure
- CA State Medical License 2010 - 2025
- NY State Medical License 2011 - 2015
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 47 citationsPopulation pharmacokinetic and covariate analysis of pertuzumab, a HER2‑targeted monoclonal antibody, and evaluation of a fixed, non‑weight‑based dose in patients with...Amit Garg, Angelica Quartino, Jing Li, Jin Jin, D. Russell Wada
Cancer Chemotherapy and Pharmacology. 2014-08-14 - 18 citationsPharmacokinetic and exposure–response analyses of pertuzumab in combination with trastuzumab and docetaxel during neoadjuvant treatment of HER2+ early breast cancerAngelica Quartino, Hanbin Li, Jin Y. Jin, D. Russell Wada, Mark C. Benyunes
Cancer Chemotherapy and Pharmacology. 2017-01-10 - 22 citationsPopulation pharmacokinetic and covariate analyses of intravenous trastuzumab (Herceptin ® ), a HER2-targeted monoclonal antibody, in patients with a variety of solid t...Angelica Quartino, Hanbin Li, Whitney P. Kirschbrown, Ranvir Mangat, D. Russell Wada
Cancer Chemotherapy and Pharmacology. 2019-02-01
Press Mentions
- Optimizing Outcomes for Patients with Metastatic Prostate Cancer: Insights from South East Asia Expert PanelFebruary 23rd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: